Use of Race in eGFR – Is it a relevant measure?

Title: Use of Race in eGFR – Is it a relevant measure?

Moderator: Richard Knight, AAKP President, former dialysis patient, current transplant recipient

Speaker: Crystal A. Gadegbeku, MD, FASN, Founding Member, Diversity, and Inclusion Committee;
Member, Public Policy Board, American Society of Nephrology (ASN)

As the oldest and largest, independent kidney patient organization in the U.S. – AAKP is dedicated to improving the lives and long-term outcomes of kidney patients through education, advocacy, patient engagement and the fostering of patient communities. AAKP fights for early disease detection and the appropriate diagnosis of rare/genetic conditions; increased kidney transplantation and pre-emptive transplantation; full patient choice of either in-center or home dialysis; protection of the patient/physician relationship; promotion of research and innovation including artificial implantable and wearable kidneys; and the elimination of barriers for patient access to available treatment options. Learn more at www.aakp.org.